A detailed history of New York State Common Retirement Fund transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 6,710 shares of TBPH stock, worth $66,093. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,710
Previous 6,710 -0.0%
Holding current value
$66,093
Previous $57,000 5.26%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$8.29 - $9.92 $100,234 - $119,942
-12,091 Reduced 64.31%
6,710 $57,000
Q1 2024

May 07, 2024

SELL
$8.22 - $11.59 $624 - $880
-76 Reduced 0.4%
18,801 $169,000
Q4 2023

Feb 01, 2024

SELL
$8.58 - $11.4 $1,003 - $1,333
-117 Reduced 0.62%
18,877 $212,000
Q3 2023

Nov 07, 2023

SELL
$8.38 - $10.44 $46,190 - $57,545
-5,512 Reduced 22.49%
18,994 $164,000
Q2 2023

Aug 07, 2023

SELL
$10.16 - $11.92 $93,116 - $109,246
-9,165 Reduced 27.22%
24,506 $254,000
Q1 2023

May 02, 2023

SELL
$9.87 - $11.44 $98,532 - $114,205
-9,983 Reduced 22.87%
33,671 $365,000
Q4 2022

Jan 30, 2023

SELL
$9.65 - $11.34 $48 - $56
-5 Reduced 0.01%
43,654 $490,000
Q3 2022

Nov 08, 2022

BUY
$8.39 - $10.22 $1,182 - $1,441
141 Added 0.32%
43,659 $443,000
Q2 2022

Aug 04, 2022

BUY
$8.41 - $10.34 $64,765 - $79,628
7,701 Added 21.5%
43,518 $394,000
Q1 2022

May 05, 2022

BUY
$8.33 - $12.96 $91 - $142
11 Added 0.03%
35,817 $342,000
Q4 2021

Feb 02, 2022

BUY
$7.42 - $11.05 $50,864 - $75,747
6,855 Added 23.68%
35,806 $396,000
Q3 2021

Nov 02, 2021

SELL
$6.77 - $14.41 $126,890 - $270,086
-18,743 Reduced 39.3%
28,951 $214,000
Q2 2021

Aug 02, 2021

BUY
$14.52 - $22.46 $91,388 - $141,363
6,294 Added 15.2%
47,694 $693,000
Q2 2020

Aug 07, 2020

SELL
$20.64 - $30.69 $16,512 - $24,552
-800 Reduced 1.9%
41,400 $869,000
Q4 2019

Feb 05, 2020

SELL
$16.12 - $25.89 $95,108 - $152,751
-5,900 Reduced 12.27%
42,200 $1.09 Million
Q3 2019

Nov 07, 2019

BUY
$16.51 - $23.78 $99,060 - $142,680
6,000 Added 14.25%
48,100 $937,000
Q4 2018

Feb 08, 2019

SELL
$22.52 - $35.07 $94,584 - $147,294
-4,200 Reduced 9.07%
42,100 $1.08 Million
Q2 2017

Aug 11, 2017

BUY
N/A
46,300
46,300 $1.85 Million

Others Institutions Holding TBPH

About Theravance Biopharma, Inc.


  • Ticker TBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,782,400
  • Market Cap $658M
  • Description
  • Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...
More about TBPH
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.